Form 4 · LLY
Eli Lilly EVP & CFO Lucas Montarce reports exercising or converting 1,610 shares
Part of a grouped insider digest: see all related filings with totals →
Lucas Montarce, Eli Lilly's EVP & CFO, filed a Form 4 on Nov 3, 2026 at 4:14 PM ET reporting transactions on Nov 1, 2026.
The filing reports 1,610 shares in an exercise or conversion of a derivative security (code M); and about 678 shares withheld to pay the exercise price or tax (code F).
After these transactions, the filing lists about 17,191 shares held directly.
Effect on holdings
Taken together, the rows reported here raised Lucas Montarce's directly held shares by 5.7%, from about 16,258 to about 17,191.
Reporting person
- Lucas Montarce, EVP & CFO (as filed: Montarce Lucas)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-01 | M | Common Stock | 1,610 | Acquired | 17,868 | Direct | |
| 2026-11-01 | F | Common Stock | 678 | $1,417.54 | Disposed | 17,191 | Direct |
| 2026-11-01 | M | Restricted Stock Unit (derivative) | 1,610 | Disposed | 0 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 3, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Eli Lilly company file → · More Eli Lilly filings
Disclosures
- Editor holdings in LLY
- The editor holds no position in Eli Lilly (LLY). As of Nov 11, 2026.
- Last updated
- Nov 3, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.